1887
  1. Home
  2. Eurosurveillance
  3. Volume 27, Issue 16, 21/Apr/2022
  4. Article
Surveillance Open Access
Like 0
Download

Abstract

Background

The COVID-19 pandemic presented new challenges for the existing respiratory surveillance systems, and adaptations were implemented. Systematic assessment of the syndromic and sentinel surveillance platforms during the pandemic is essential for understanding the value of each platform in the context of an emerging pathogen with rapid global spread.

Aim

We aimed to evaluate systematically the performance of various respiratory syndromic surveillance platforms and the sentinel surveillance system in Israel from 1 January to 31 December 2020.

Methods

We compared the 2020 syndromic surveillance trends to those of the previous 3 years, using Poisson regression adjusted for overdispersion. To assess the performance of the sentinel clinic system as compared with the national SARS-CoV-2 repository, a cubic spline with 7 knots and 95% confidence intervals were applied to the sentinel network's weekly percentage of positive SARS-CoV-2 cases.

Results

Syndromic surveillance trends changed substantially during 2020, with a statistically significant reduction in the rates of visits to physicians and emergency departments to below previous years' levels. Morbidity patterns of the syndromic surveillance platforms were inconsistent with the progress of the pandemic, while the sentinel surveillance platform was found to reflect the national circulation of SARS-CoV-2 in the population.

Conclusion

Our findings reveal the robustness of the sentinel clinics platform for the surveillance of the main respiratory viruses during the pandemic and possibly beyond. The robustness of the sentinel clinics platform during 2020 supports its use in locations with insufficient resources for widespread testing of respiratory viruses.

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2022.27.16.2100457
2022-04-21
2024-04-19
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2022.27.16.2100457
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/27/16/eurosurv-27-16-5.html?itemId=/content/10.2807/1560-7917.ES.2022.27.16.2100457&mimeType=html&fmt=ahah

References

  1. Patel A, Jernigan DB, 2019-nCoV CDC Response Team. Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak — United States, December 31, 2019–February 4, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(5):140-6.  https://doi.org/10.15585/mmwr.mm6905e1  PMID: 32027631 
  2. Lee EC, Wada NI, Grabowski MK, Gurley ES, Lessler J. The engines of SARS-CoV-2 spread. Science. 2020;370(6515):406-7.  https://doi.org/10.1126/science.abd8755  PMID: 33093098 
  3. Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed. 2020;91(1):157-60. PMID: 32191675 
  4. World Health Organization (WHO). Laboratory testing strategy recommendations for COVID-19. Interim guidance 21 March 2020. Geneva: WHO; 2020. Available from: https://apps.who.int/iris/bitstream/handle/10665/331509/WHO-COVID-19-lab_testing-2020.1-eng.pdf
  5. World Health Organization (WHO). Surveillance strategies for COVID-19 human infection. Coronavirus (COVID-19) update no. 29, 5 June 2020. Geneva: WHO; 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/risk-comms-updates/update-29-surveillance-strategies-for-covid-19-human-infection.pdf?sfvrsn=3c2cab92_2
  6. Bromberg M, Keinan-Boker L, Gur-Arie L, Sefty H, Mandelboim M, Dichtiar R, et al. Monitoring SARS-CoV-2 activity with sentinel surveillance: lessons learned from the first wave in Israel. Isr Med Assoc J. 2022;24(4):215-8. PMID: 35415978 
  7. Israel Ministry of Health (MOH). Coronavirus: update from 9.2.2020. Jerusalem: MOH; 9 February 2020. Hebrew. Available from: https://www.health.gov.il/NewsAndEvents/SpokemanMesseges/Pages/09022020_3.aspx
  8. Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020;25(3):2000045.  https://doi.org/10.2807/1560-7917.ES.2020.25.3.2000045  PMID: 31992387 
  9. Public Health England (PHE). GP in hours. Syndromic surveillance system: England. Year 2020, week 53. London: PHE; 2021. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/950199/GPinHoursEngBulletin2020Wk53.pdf
  10. Boëlle PY, Souty C, Launay T, Guerrisi C, Turbelin C, Behillil S, et al. Excess cases of influenza-like illnesses synchronous with coronavirus disease (COVID-19) epidemic, France, March 2020. Euro Surveill. 2020;25(14):2000326.  https://doi.org/10.2807/1560-7917.ES.2020.25.14.2000326  PMID: 32290901 
  11. Silverman JD, Hupert N, Washburne AD. Using influenza surveillance networks to estimate state-specific prevalence of SARS-CoV-2 in the United States. Sci Transl Med. 2020;12(554):eabc1126.  https://doi.org/10.1126/scitranslmed.abc1126  PMID: 32571980 
  12. Hartnett KP, Kite-Powell A, DeVies J, Coletta MA, Boehmer TK, Adjemian J, et al. Impact of the COVID-19 pandemic on emergency department visits — United States, January 1, 2019–May 30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(23):699-704.  https://doi.org/10.15585/mmwr.mm6923e1  PMID: 32525856 
  13. Liguoro I, Pilotto C, Vergine M, Pusiol A, Vidal E, Cogo P. The impact of COVID-19 on a tertiary care pediatric emergency department. Eur J Pediatr. 2021;180(5):1497-504.  https://doi.org/10.1007/s00431-020-03909-9  PMID: 33409588 
  14. Steinman M, de Sousa JHB, Tustumi F, Wolosker N. The burden of the pandemic on the non-SARS-CoV-2 emergencies: A multicenter study. Am J Emerg Med. 2021;42:9-14.  https://doi.org/10.1016/j.ajem.2020.12.080  PMID: 33429189 
  15. Perry Markovich M, Glatman-Freedman A, Bromberg M, Augarten A, Sefty H, Kaufman Z, et al. Back-to-school upper respiratory infection in preschool and primary school-age children in Israel. Pediatr Infect Dis J. 2015;34(5):476-81.  https://doi.org/10.1097/INF.0000000000000627  PMID: 25879647 
  16. Heymann A, Chodick G, Reichman B, Kokia E, Laufer J. Influence of school closure on the incidence of viral respiratory diseases among children and on health care utilization. Pediatr Infect Dis J. 2004;23(7):675-7.  https://doi.org/10.1097/01.inf.0000128778.54105.06  PMID: 15247610 
  17. Silverberg SL, Zhang BY, Li SNJ, Burgert C, Shulha HP, Kitchin V, et al. Child transmission of SARS-CoV-2: a systematic review and meta-analysis. BMC Pediatr. 2022;22(1):172.  https://doi.org/10.1186/s12887-022-03175-8  PMID: 35365104 
  18. Viner R, Waddington C, Mytton O, Booy R, Cruz J, Ward J, et al. Transmission of SARS-CoV-2 by children and young people in households and schools: A meta-analysis of population-based and contact-tracing studies. J Infect. 2022;84(3):361-82.  https://doi.org/10.1016/j.jinf.2021.12.026  PMID: 34953911 
  19. The World Bank. Fertility rate, total (births per woman). Washington, DC: The World Bank. [Accessed: 4 Apr 2022]. Available from: https://data.worldbank.org/indicator/SP.DYN.TFRT.IN
  20. Hodcroft EB, Hadfield J, Neher RA, Bedford T. Year-letter genetic clade naming for SARS-CoV-2 on Nextstrain.org. Nexstrain blog; 2020. Available from: https://nextstrain.org/blog/2020-06-02-SARSCoV2-clade-naming
  21. Miller D, Martin MA, Harel N, Tirosh O, Kustin T, Meir M, et al. Full genome viral sequences inform patterns of SARS-CoV-2 spread into and within Israel. Nat Commun. 2020;11(1):5518.  https://doi.org/10.1038/s41467-020-19248-0  PMID: 33139704 
  22. Zhang Y, Zhang H, Zhang W. SARS-CoV-2 variants, immune escape, and countermeasures. Front Med. 2022;1-12. PMID: 35253097 
  23. Israel Ministry of Health (MOH). Four cases of COVID-19 variant found in the United Kingdom have been discovered in Israel. Jerusalem: MOH; 23 December 2020. Available from: https://www.gov.il/en/departments/news/23122020-07
  24. Singer SR, Angulo FJ, Swerdlow DL, McLaughlin JM, Hazan I, Ginish N, et al. Effectiveness of BNT162b2 mRNA COVID-19 vaccine against SARS-CoV-2 variant Beta (B.1.351) among persons identified through contact tracing in Israel: A prospective cohort study. EClinicalMedicine. 2021;42:101190.  https://doi.org/10.1016/j.eclinm.2021.101190  PMID: 34870134 
  25. World Health Organization (WHO). Influenza update 387. Geneva: WHO; 2021. Available from: https://www.who.int/publications/m/item/influenza-update-n-387
  26. Florida department of Health. Respiratory syncytial virus surveillance. Week 5. Tallahassee: Florida Health. [Accessed: 10 Dec 2021]. Available from: http://www.floridahealth.gov/diseases-and-conditions/respiratory-syncytial-virus/_documents/2021-w5-rsv-summary.pdf
  27. World Health Organization (WHO). influenza update 376. Geneva: WHO; 2020. Available from: https://www.who.int/publications/m/item/influenza-update-n-376
  28. Yeoh DK, Foley DA, Minney-Smith CA, Martin AC, Mace AO, Sikazwe CT, et al. Impact of coronavirus disease 2019 public health measures on detections of influenza and respiratory syncytial virus in children during the 2020 Australian winter. Clin Infect Dis. 2021;72(12):2199-202.  https://doi.org/10.1093/cid/ciaa1475  PMID: 32986804 
The impact of SARS-CoV-2 on respiratory syndromic and sentinel surveillance in Israel, 2020: a new perspective on established systems
<p class="citation"> <span>Citation style for this article:</span> <span class="meta-value authors"> <a href="/search?value1=Aharona+Glatman-Freedman&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Glatman-Freedman Aharona</a>, <a href="/search?value1=Lea+Gur-Arie&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Gur-Arie Lea</a>, <a href="/search?value1=Hanna+Sefty&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Sefty Hanna</a>, <a href="/search?value1=Zalman+Kaufman&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Kaufman Zalman</a>, <a href="/search?value1=Michal+Bromberg&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Bromberg Michal</a>, <a href="/search?value1=Rita+Dichtiar&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Dichtiar Rita</a>, <a href="/search?value1=Alina+Rosenberg&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Rosenberg Alina</a>, <a href="/search?value1=Rakefet+Pando&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Pando Rakefet</a>, <a href="/search?value1=Ital+Nemet&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Nemet Ital</a>, <a href="/search?value1=Limor+Kliker2%2C&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Kliker2, Limor</a>, <a href="/search?value1=Ella+Mendelson&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Mendelson Ella</a>, <a href="/search?value1=Lital+Keinan-Boker&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Keinan-Boker Lital</a>, <a href="/search?value1=Neta+S+Zuckerman&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Zuckerman Neta S</a>, <a href="/search?value1=Michal+Mandelboim&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Mandelboim Michal</a>, <a href="/search?value1=on+behalf+of+The+Israeli+Respiratory+Viruses+Surveillance+Network+%28IRVSN%29&option1=author&noRedirect=true" class="nonDisambigAuthorLink">on behalf of The Israeli Respiratory Viruses Surveillance Network (IRVSN)</a></span>. The impact of SARS-CoV-2 on respiratory syndromic and sentinel surveillance in Israel, 2020: a new perspective on established systems. <a href="/content/ecdc">Euro Surveill.</a> 2022;27(16):pii=2100457. <a href="https://doi.org/10.2807/1560-7917.ES.2022.27.16.2100457" title="doi link" target="_blank">https://doi.org/10.2807/1560-7917.ES.2022.27.16.2100457</a> <span class="ES_Article_citation"> <span class="generated">Received</span>: 18 May 2021;&nbsp;&nbsp; <span class="generated">Accepted</span>: 16 Jan 2022 </span> </p>
/content/10.2807/1560-7917.ES.2022.27.16.2100457
/content/10.2807/1560-7917.ES.2022.27.16.2100457
Loading

Data & Media loading...

Supplementary data

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error